Pharmafile Logo
Pharmafocus logo
Advanced Search
takeda_world

Takeda acquires investigational coeliac disease therapy

October 23, 2019
Research and Development

Takeda has acquired licensing for a first-in-class investigational coeliac disease therapy CNP-101/TAK-101. The Japanese pharma giant now has the rights …

News
shutterstock_159488225

Porton Biopharma signs potential $24m deal to push its intranasal anthrax vaccine into Phase 1 trials

October 22, 2019
Manufacturing and Production, Research and Development FDA, Porton Biopharma, anthrax, pharma

Porton Biopharma has signed a modification to its existing agreement with the US National Institute of Health’s National Institute of …

News

Novo Nordisk opens first Pharmatech branch office in Singapore

October 22, 2019
Manufacturing and Production Novo Nordisk, Singapore, pharma

Novo Nordisk has celebrated the launch of a new Pharmatech A/S branch office based in Singapore at a grand opening …

News
teva_copy

Teva offers massive $23 billion to avoid thousands of lawsuits

October 22, 2019
Manufacturing and Production

Israeli drug company Teva has said that it would offer $250 million in cash and a supply of Suboxone, an …

News
cruk_logo

Cancer Research UK announces push for earlier cancer detection

October 22, 2019
Manufacturing and Production

Cancer Research UK has embarked on a new international alliance with a plan to develop ‘radical new strategies’ and technologies …

News
vertex-headquarters

US FDA approves Vertex’s new breakthrough therapy for cystic fibrosis

October 22, 2019
Manufacturing and Production

The US FDA has approved Trikafta (elexacaftor/ivacaftor/tezacaftor) – the first triple combination therapy available for patients with most common cystic …

News
brexit-hintergrund_web

“No deal” Brexit and life sciences: What happens?

October 21, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EU, Europe, UK, brexit, no deal, no-deal, pharma

Prime Minister Boris Johnson may have agreed a withdrawal agreement with the European Union at the 11th hour, but despite …

Feature
alexion_sign

FDA approves Alexion’s Ultomiris in atypical haemolytic uremic syndrome for adults and children

October 21, 2019
Sales and Marketing Alexion, FDA, Ultomiris, pharma, rare disease

The FDA has moved to expand the existing label for Alexion’s Ultomiris (ravulizumab-cwvz) to include the treatment of atypical haemolytic …

News
ema_logo

CHMP recommends several drugs for EU market approval

October 21, 2019
Sales and Marketing

The EMA’s human medicines committee (CHMP) has recommended seven medicines for approval at its October 2019 meet including MSD’s Ervebo, …

News
rocheshanghai

Roche’s Tecentriq/Avastin combo smashes endpoints at Phase 3 in unresectable hepatocellular carcinoma

October 21, 2019
Research and Development, Sales and Marketing Cancer, Roche, immunotherapy, pharma, tecentriq

New Phase 3 data has emerged demonstrating the efficacy of Roche’s Tecentriq (atezolizumab) in combination with Avastin (bevacizumab) in the …

News
astrazeneca_sign_sky

AstraZeneca receives FDA approval for Farxiga

October 21, 2019
Sales and Marketing

AstraZeneca have announced that the US FDA has approved Farxiga (dapagliflozin) to reduce the risk of hospitalisation for heart failure …

News
gsk_boronia_australia

GlaxoSmithKline sells two vaccines for up to £822m

October 21, 2019
Sales and Marketing

GlaxoSmithKline has announced it will divest two of its major vaccines to Denmark-based Bavarian Nordic in a deal that will …

News

Medical cannabis: Growth by leaps and bounds

October 18, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Canada, Canopy Growth, medical cannabis, pharma

This article follows parts one and two of our trio of in-depth pieces focusing on the growing medical cannabis phenomenon. …

Feature
top_10_photo

Top Ten most popular articles on Pharmafile.com this week

October 18, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

It’s time for a rundown of the top 10 articles on PharmaFile this past week. The past seven days saw …

News
dw-anzcxqaqavhl

2019 saw the FDA approve more generic drugs than ever before

October 18, 2019
Medical Communications, Sales and Marketing FDA, US, generic drugs, pharma

Fiscal year 2019 was a record-breaking one, according to the FDA. The US regulator smashed its previous total for annual …

News
shionogi

FDA panel gives positive vote for Shionogi’s Cefiderocol in Urinary Tract Infections

October 18, 2019
Medical Communications

The US FDA has recommended approval for cefiderocol, a novel antibiotic for complicated urinary tract infections, including pyelonephritis, in patients …

News
genentech_web

FDA greenlights Genentech’s Xofluza for acute, uncomplicated influenza

October 18, 2019
Medical Communications FDA, Genetech, Roche, US, Xofluza, flu, pharma

Roche subsidiary Genentech has announced that its polymerase acidic endonuclease inhibitor Xofluza (baloxavir marboxil) has been awarded FDA approval in …

News
merckincweb1

MSD to cut around 500 jobs in US next year

October 18, 2019
Medical Communications

MSD have announced it plans to eliminate approximately 500 jobs in multiple US states according to a filing with the …

News
3113439955_5963062014_o

Drug manufacturers to settle US opioid litigation with $50 billion package

October 17, 2019
Business Services

Five drug makers and distributors are now offering $22 billion in cash, as well as drugs and services, valued at …

News

UCB’s bimekizumab meets primary and secondary endpoints, beating Janssen’s Stelara in chronic plaque psoriasis

October 17, 2019
Research and Development Stelara, UCB Pharma, bimekizumab, pharma, plaque psoriasis

UCB Pharma has announced new data from the first of three Phase 3 studies investigating the efficacy of its IL-17A …

News
The Gateway to Local Adoption Series

Latest content

Complement Therapeutics’ geographic atrophy treatment receives FDA Fast Track designation

January 22, 2026

PSI appoints David Allen as Country Manager for Canada

January 22, 2026

Qureight appoints Steven Bishop as Chief Medical Officer

January 21, 2026

Pierre Fabre Laboratories and Iktos announce oncology collaboration

January 21, 2026

Qureight appoints Rebecca Simmons as Chief Operating Officer

January 20, 2026